The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The objective of this multi-center prospective observational clinical study is to evaluate the clinical performance of the Carisome Prostate assay as an aid in the diagnosis of prostate cancer in men that have been scheduled for a prostate biopsy. Primarily, results of the Carisome Prostate assay will be compared with pathology results of prostate biopsy procedures. Secondarily, the performance of the Carisome Prostate test will be compared to the current standard of care for the detection of prostate cancer.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Men scheduled for routine prostate biopsy
Men scheduled for a routine prostate biopsy expected to produce a pathology evaluation and report
Blood draw within 7 days prior to scheduled prostate biopsy procedure
Blood draw on the day of but prior to biopsy
Any previous diagnosis of cancer with the exception of non-melanoma skin cancer
Any prior or ongoing treatment for prostate cancer including prostatectomy or hormone therapy
Prostate biopsy within one month of blood draw
Previous enrollment in the Caris Life Sciences Biorepository